title: Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.
authors.affiliation: Duke University, Center for AIDS Research Central QA Unit, Durham, North Carolina, United States of America. msarzott@duke.edu
authors.forename: Marcella
authors.initials: M
authors.lastname: Sarzotti-Kelsoe
authors.forename: Josephine
authors.initials: J
authors.lastname: Cox
authors.forename: Naana
authors.initials: N
authors.lastname: Cleland
authors.forename: Thomas
authors.initials: T
authors.lastname: Denny
authors.forename: John
authors.initials: J
authors.lastname: Hural
authors.forename: Leila
authors.initials: L
authors.lastname: Needham
authors.forename: Daniel
authors.initials: D
authors.lastname: Ozaki
authors.forename: Isaac R
authors.initials: IR
authors.lastname: Rodriguez-Chavez
authors.forename: Gwynneth
authors.initials: G
authors.lastname: Stevens
authors.forename: Timothy
authors.initials: T
authors.lastname: Stiles
authors.forename: Tony
authors.initials: T
authors.lastname: Tarragona-Fiol
authors.forename: Anita
authors.initials: A
authors.lastname: Simkins
mesh_terms: D019411:Clinical Laboratory Techniques / Q000592:standards*; D017321:Clinical Trials, Phase I as Topic / Q000592:standards*; D017322:Clinical Trials, Phase II as Topic / Q000592:standards*; D017326:Clinical Trials, Phase III as Topic / Q000592:standards*; D006801:Humans; D017410:Practice Guidelines as Topic